SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 12, 2017 12:30 pm UTC| Business
Raised $28.2 Million in Net Proceeds in a Private Placement Received a Favorable IPR Ruling Invalidating United Therapeutics’ ‘393 PatentCompleted a Clinical Validation Study for Trevyent®On Track to file a New Drug...
Wilhelmina International, Inc. Reports Revenue for First Quarter 2017
May 12, 2017 12:30 pm UTC| Business
First Quarter Financial Highlights Revenues for the first quarter ended March 31, 2017 were $19.2 million, a decrease of 10.6% from the same period prior year.Operating income was $101 thousand, an increase of 3.1% for...
Apache Declares Cash Dividend on Common Shares
May 12, 2017 12:30 pm UTC| Business
HOUSTON, May 12, 2017 -- The board of directors of Apache Corporation (NYSE:APA) (Nasdaq:APA) has declared the regular cash dividend on the company's common shares. The dividend on common shares is payable Aug. 22,...
EXL Launches its Digital Experience Center in Jersey City, NJ
May 12, 2017 12:30 pm UTC| Business
NEW YORK, May 12, 2017 -- EXL (NASDAQ:EXLS), a leading operations management and analytics company, today announced that it has launched its state-of-the-art Digital Experience Center in Jersey City, NJ. Located just 20...
Bulletin from BTS Group AB's Annual General Meeting
May 12, 2017 12:15 pm UTC| Business
The Annual General Meeting resolved on the proposed dividend to shareholders of SEK 2.50 per share. The record date for dividend was determined to Tuesday, May 16, 2017. The dividend is expected to be paid as of Friday,...
Valeritas Reports First Quarter 2017 Financial Results
May 12, 2017 12:05 pm UTC| Business
BRIDGEWATER, N.J., May 12, 2017 -- Valeritas Holdings, Inc. (Nasdaq:VLRX) today announced financial results for the first quarter ended March 31, 2017. First Quarter 2017 and Recent Highlights: Revenues of $4.6...
May 12, 2017 12:05 pm UTC| Business
--Positive dose response in central nervous system with 60.7% +/- 8.8% reduction of disease-causing heparan sulfate GAG observed in Cohort 2--Reduction of disease manifestation observed in decreased liver volume of 14.81%...